• 1809 Ashland Avenue
  • Room 212
  • Baltimore, MD 21205

Andrew W. Siegel

Andrew W. Siegel, JD, PhD, is a Research Scholar in the Johns Hopkins Berman Institute of Bioethics. He is also a faculty member of the Johns Hopkins University Information Security Institute and Affiliate Faculty at the Kennedy Institute of Ethics at Georgetown. He received his JD and PhD in Philosophy from the University of Wisconsin-Madison. Dr. Siegel was a Greenwall Fellow in Bioethics and Health Policy. He has served as Staff Philosopher for the National Bioethics Advisory Commission, Legislative Fellow for Senator Edward M. Kennedy and the Labor and Human Resources Committee, and Staff Attorney for the Task Force on Genetic Testing of the Working Group on the Ethical, Legal and Social Issues of the Human Genome Project. He has taught philosophy at Johns Hopkins and Georgetown, and law at Georgetown and the University of Wisconsin. His current research focuses on ethical and legal issues in human stem cell research, exploitation in research, and privacy.

Education:

PhD, University of Wisconsin-Madison
JD, University of Wisconsin-Madison

Recent Publications:

1: Siegel, AW.  Philosophical Issues in Human Pluripotent Stem Cell Research, in K. Kampourakis, ed., Philosophical Issues in Biology Education (Springer, forthcoming).

2: Duggan P., Siegel AW et al., Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges.  American Journal of Bioethics-Neuroscience 2009 May;9(5): 31-36.

3: Sugarman, J., & Siegel, A. W. (2008). When embryonic stem cell lines fail to meet consent standards. Science322(5900), 379-379.

4:  Siegel AW, Kantian Ethics, Exploitation and Multinational Clinical Trials, in Hawkins JS and Emanuel EJ, Exploitation and Developing Countries (Princeton, 2008): 175-205

5: Siegel, A. W. (2008). Inequality, privacy, and mental health. International journal of law and psychiatry31(2), 150-157.

6: Siegel, A. W. (2004). Temporal restrictions and the impasse on human embryonic stem-cell research. The Lancet364(9429), 215-218.